APA

Nakagawa M., Nakatani F., Matsunaga H., Seki T., Endo M., Ogawara Y., Machida Y., Katsumoto T., Yamagata K., Hattori A., Fujita S., Aikawa Y., Ishikawa T., Soga T., Kawai A., Chuman H., Yokoyama N., Fukushima S., Yahiro K., Kimura A., Shimada E., Hirose T., Fujiwara T., Setsu N., Matsumoto Y., Iwamoto Y., Nakashima Y. & Kitabayashi I. (20200226). Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. : Oncogene.

Chicago

Nakagawa Makoto, Nakatani Fumihiko, Matsunaga Hironori, Seki Takahiko, Endo Makoto, Ogawara Yoko, Machida Yukino, Katsumoto Takuo, Yamagata Kazutsune, Hattori Ayuna, Fujita Shuhei, Aikawa Yukiko, Ishikawa Takamasa, Soga Tomoyoshi, Kawai Akira, Chuman Hirokazu, Yokoyama Nobuhiko, Fukushima Suguru, Yahiro Kenichiro, Kimura Atsushi, Shimada Eijiro, Hirose Takeshi, Fujiwara Toshifumi, Setsu Nokitaka, Matsumoto Yoshihiro, Iwamoto Yukihide, Nakashima Yasuharu and Kitabayashi Issay. 20200226. Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. : Oncogene.

Harvard

Nakagawa M., Nakatani F., Matsunaga H., Seki T., Endo M., Ogawara Y., Machida Y., Katsumoto T., Yamagata K., Hattori A., Fujita S., Aikawa Y., Ishikawa T., Soga T., Kawai A., Chuman H., Yokoyama N., Fukushima S., Yahiro K., Kimura A., Shimada E., Hirose T., Fujiwara T., Setsu N., Matsumoto Y., Iwamoto Y., Nakashima Y. and Kitabayashi I. (20200226). Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. : Oncogene.

MLA

Nakagawa Makoto, Nakatani Fumihiko, Matsunaga Hironori, Seki Takahiko, Endo Makoto, Ogawara Yoko, Machida Yukino, Katsumoto Takuo, Yamagata Kazutsune, Hattori Ayuna, Fujita Shuhei, Aikawa Yukiko, Ishikawa Takamasa, Soga Tomoyoshi, Kawai Akira, Chuman Hirokazu, Yokoyama Nobuhiko, Fukushima Suguru, Yahiro Kenichiro, Kimura Atsushi, Shimada Eijiro, Hirose Takeshi, Fujiwara Toshifumi, Setsu Nokitaka, Matsumoto Yoshihiro, Iwamoto Yukihide, Nakashima Yasuharu and Kitabayashi Issay. Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. : Oncogene. 20200226.